Wertigkeit und Grenzen der Low-dose-Heparin-Prophylaxe zur Verhütung postoperativer thromboembolischer Komplikationen

• LITERATUR

• 1 Abernethy E. E, Hartsuck J. M. Postoperative pulmonary embolism. A prospective study utilizing low-dose heparin. Amer. J. Surg 1974; 188: 739-742.
• 2 Adolf J, Buttermann G, Weidenbach A, Gmeineder F. Optimierung der postoperativen Thromboseprophylaxe in der Gynäkologie. Geburtsh. u. Frauenheilk 1978; 38: 98-104.
• 3 Ballard R. M, Bradley-Watson P. J, Johnstone F. D, Kenney A, McCarthy T. G, Campbell S, Weston J. Low-doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery. J. Obstet. Gynaec. Brit. Cwlth 1973; 80: 469
• 4 Baertschi U, Schaer A, Bader P, Huber L, Morf P. Thromboseprophylaxe nach gynäkologischen Operationen: Eine Vergleichsstudie von Low-dose-Heparin und oralen Antikoagulantien. Geburtsh. u. Frauenheilk 1975; 35: 754-760.
• 5 Barber H. M, Feil E. J, Galasko C. S. B, Edwards D. H, Sutton R. A, Haynes D. W, Bentley G. A comparative study of dextran-70 warfarin and low-dose heparin for the prophylaxis of thromboembolism following total hip replacement. Postgrad. Med. J 1977; 53: 130-133.
• 6 Becker J, Borgström G-F. Saltzman: Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. Acta Chir. Scand 1970; 136: 167-171.
• 7 Becker J, Schampi B. The incidence of postoperative venous thrombosis of the legs. Acta chir. Scand 1973; 139: 357-367.
• 8 Bergqvist D, Efsing H. O, Hallböök T, Hedlund T. Thromboembolism after elective and post-traumatic hip surgery- A controlled prophylactic trial with Dextran 70 and low-dose heparin. Acta chir. Scand 1979; 145: 213-218.
• 9 Bergqvist D, Hallböök T. A comparison between subcutaneous low-dose sodium and calcium heparin. Acta chir. Scand 1978; 144: 339-342.
• 10 Bergqvist D. Prophylaxis of postoperative thromboembolic complications with low-dose heparin. Acta chir. Scand 1979; 145: 7-14.
• 11 O’Brien J. R. Detection of thrombosis with iodine-125 fibrinogen. Lancet II: 396-398. 1970;
• 12 Browse N. L, Clemenson G, Croft D. N. Fibrinogen-detectable thrombosis in the legs and pulmonary embolism. Brit. med. J 1974; 1: 603-604.
• 13 Browse N. L, Jackson B. T, Mayo M. E. The value of mechanical methods of preventing postoperative calf vein thrombosis. Brit. J. Surg 1974; 61: 219-223.
• 14 Browse N. L. Die pharmakologische Prophylaxe der tiefen Venenthrombose und der Lungenembolie. Triangel 1977; 16: 29-33.
• 15 Brozovic M, Stirling Y, Abbosh J. Plasma heparin levels after low-dose subcutaneous heparin in patients undergoing hip replacement. Brit. J. Haemat 1975; 31: 461-466.
• 16 Bruhn H. D. Niedrig dosiertes Heparin. Wirkungsweise und Indikationen; Schattauer, Stuttgart - New York: 1979
• 17 Buttermann G, Theisinger W, Weidenbach A, Hartung R, Welzel D, Pabst H. W. Quantitative Bewertung der postoperativen Thromboembolieprophylaxe. Vergleichende Untersuchungen über Thrombose- und Em-boliehäufigkeit unter Acetylsalicylsäure, Dextran, Dihydroergotamin, Heparin sowie der fixen Kombination von Heparin und Dihydroergotamin. Med. Klin 1977; 72: 1624-1638.
• 18 Buttermann G, Haluszczynski I, Theisinger W, Pabst H. W. Postoperative Thrombo-embolie-Prophylaxe mit reduziertem low-dose-Heparin-Anteil und Dihydroergotamin in fixer Kombination. Münch. med. Wschr 1981; 123: 1213-1216.
• 19 Cines D. B, Kaywin P, Bina M, Tomaski A, Schreiber A. D. Heparin-associated thrombocytopenia. New Engl. J. Med 1980; 303: 788-795.
• 20 Coe N. P, Collins R. E, Klein L. A, Bettmann M. A, Skillman J. J, Shapiro R. M, Salzman W. Prevention of deep vein thrombosis in urological patients: A controlled randomized trial of low-dose heparin and external pneumatic compression boots. Surg 1978; 83: 230-234.
• 21 Coon W. W, Coller F. Clinicopathologic correlation in thromboembolism. Surg. Gynec. Obstet 1959; 109: 259
• 22 Corrigan T. P, Kakkar V. V, Fossard D. F. Low-dose subcutaneous heparin - optimal dose regimen. Brit. J. Surg 1974; 61: 320
• 23 Cristal N, Stern J, Ronen M, Silverman C, Ho W, Bartov E. Identifying patients at risk for thromboembolism. Use of ¹²⁵-labeled fibrinogen in patients with akute myocardial infarction. J. Amer. Med. Ass 1976; 236: 2755-2757.
• 24 Dechavanne M, Ville D, Víala J. J, Kher A, Faivre J, Pousset M. B, Dejour H. Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis 1975; 4: 94-100.
• 25 Dick W, Matis P, Mayer W. Results of alternating anticoagulant prophylaxis in surgery. Thrombos. Diathes. haemorrh 1959; 3: 11-19.
• 26 Dick W, Matis P, Mayer W. Ergebnisse der alternierenden Antikoagulantienprophylaxe. Chirurg 1961; 10: 443-446.
• 27 Eskelund G, Solheim K, Skjörten F. Anticoagulant prophylaxis thromboembolism and mortality in elderly patients with hip fractures A controlled clinical trial. Acta chir. Scand 1966; 131: 16-29.
• 28 Flanc C, Kakkar V. V, Clarke M. B. Postoperative deep-vein thrombosis effect of intensive prophylaxis. Lancet l: 477-478. 1969;
• 29 Flicoteaux H, Kher A, Jean N, Blery M, Judet T, Honnart F, Pasteyer J. Comparison of low dose heparin and low dose heparin combined with aspirin in prevention of deep vein thrombosis after total hip replacement. Patho. Biol. Suppl 1977; 25: 55-58.
• 30 Frishman W. H, Ribner H. S. Anticoagulation in myocardial infarction: Modern approach to an old problem. Amer. J. Card 1979; 43: 1207-1213.
• 31 Gallus A. S, Hirsh J, Tuttle R. J, Trebil-cock R, O’Brien S. E, Caroll J. J, Minden J. H, Hudecki S. M. Small subcutaneous doses of heparin in prevention of venous thrombosis. New Engl. J. Med 1973; 288: 545-551.
• 32 Gallus A. S, Hirsh J, O’Brien S. E, McBride J. A, Tuttle R. J, Gent M. Prevention of venous thrombosis with small subcutaneous doses of heparin. J. Amer. Med. Ass 1976; 235: 1980-1982.
• 33 Gallus A. S, Hirsh J. Prevention of Venous Thromboembolism. Sem. Thromb. Remostas ll: 232-290. 1976;
• 34 Gordon-Smith I. C, Hickman J. A, El Marsi S. H. The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein-thromb after prostatetectomy. Brit. J. Surg 1972; 59: 522-524.
• 35 Groote Schuur Hospital Thromboembolus Study Group. Failure of low-dose heparin to prevent significant thromboembolic complications in high-risk surgical patients interim report of prospective trial. Brit. med. J 1979; 1: 1447-1450.
• 36 Gross R. Klinik der venösen Thrombosen und Lungenembolie. Therapiewoche 1979; 28: 7595-7610.
• 37 Gruber U. F, Duckert F, Fridrich R, Torhorst J, Rem J. Prevention of postoperative thromboembolism by dextran 40 low doses of heparin, or xantionol nicotinate. Lancet l: 207-210. 1977;
• 38 Gruber U. F, Saldeen T, Brokop T, Eklöf B, Eriksson I, Goldie I, Gran L, Hohl M, Johnsson T, Kristersson S, Ljungström K. G, Lund T, Moe H. M, Svensjö E, Thomson D, Torhorst J, Trippestad A, Ulstein M. Incidence of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. Brit. med. J 1980; 280: 69-72.
• 39 Harris W. H, Salzman E. W, Athanasou-lis Ch, Waltman A. C, Baum S, DeSanc-tis R. W. Comparison of Warfarin. low-molecular-weight dextran, aspirin and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J. Bone. Joint Surg 1974; 56: 1552-1560.
• 40 Hampson W. G. J, Harris F. C, Lucas H. K, Roberts P. H. Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty. Lancet ll: 795-797. 1974;
• 41 Havig Ö. Deep vein thrombosis and pulmonary embolism. Acta chir. Scand. Suppl 1977; 478: 1-120.
• 42 Hedlund P. O. Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients with the ¹²⁵I-fibrinogen uptake test. Scand. J. Urol. Nephrol. Suppl. 27 1975
• 43 Hirsh J, Gallus A. S. ¹²⁵I-labelled fibrinogen scanning. Use in the diagnosis of venous thrombosis. J. Amer. Med. Ass 1975; 233: 970-973.
• 44 Hobbs J. T, Davies J. W. L. Detection of venous thrombosis with ¹³¹-labelled fibrinogen in the rabbit. Lancet ll: 134-135. 1960;
• 45 Hohl M, Lüscher K. P, Gruber U. F. Nebenwirkungen bei perioperativer Thromboem-bolieprophylaxe. Gynäkologe 1978; 11: 45-53.
• 46 Hohl M. K, Lüscher K. P, Annaheim M, Fridrich R, Gruber U. F. Dihydroergotamine and heparin or heparin alone for the prevention of postoperative thromboembolism in gynecology. Arch. Gynecol 1980; 230: 15-19.
• 47 v. Hospenthal J, Rutishauser G, Frey Ch, Gruber U. F. Thromboseprophylaxe bei transurethraler Prostataresektion. Urologe A 1977; 16: 88-92.
• 48 Hrushesky W. J. Subcutanneous heparin-in-duced thrombocytopenia. Arch. int. Med 1978; 138: 1489-1491.
• 49 Hume M, Kuriakose T. X, Zuch Linda, Turner R. H. ¹²⁵I-fibrinogen and the prevention of venous thrombosis. Arch. Surg 1973; 107: 803-806.
• 50 Hume M. Venous thrombosis: Mechanism and treatment. Adv. Exerpta Med. Biol 1978; 102: 215-224.
• 51 Hutter O, Duckert F, Fridrich R, Gruber U. F. Dextran 40 zur Prophylaxe tiefer Venenthrombosen in der Chirurgie. Dtsch. med. Wschr 1976; 101: 1834-1837.
• 52 Joffe S. Drug prevention of postoperative deep vein thrombosis. Arch. Surg 1976; 111: 37-40.
• 53 Joffe S. N. The incidence of postoperative deep vein thrombosis. Thrombos. Res 1975; 7: 141-148.
• 54 International Multicentre Trial. Prevention of fatal postoperative pulmonary embolism by low-doses of heparin. Lancet ll: 45-51. 1975;
• 55 Kaiser D, Strey M, Hau A. Optimierte Thromboseprophylaxe in der Thoraxchirurgie. Kontrollierte Untersuchungen mit Hepa-rin-Dihydergot. Krankenhausarzt 1981; 54: 692-698.
• 56 Kakkar V. V, Nicolaides A. N, Renney J. T. G, Friend J. R. ¹²⁵I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet l: 540-542. 1970;
• 57 Kakkar V. V, Field E. S, Nicolaides A. N, Flute P. T, Wessler S, Yin E. T. Low doses of heparin in prevention of deep-vein thrombosis. Lancet ll: 669-671. 1971;
• 58 Kakkar V. V, Lawrence D, Bentley P. G, de Haas H. A, Ward V. P, Scully M. F. A comparative study of low doses heparin and a heparin analogue in the prevention of postoperative deep vein thrombosis. Thromb. Res 1978; 13: 111-122.
• 59 Kakkar V. V, Corrigan T, Spindler J, Fossard D. P, Flute P. T, Crellin R. Q, Wessler S, Yin E. T. Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery: a double blind randomized trial. Lancet ll: 101-106. 1972;
• 60 Kakkar V. The diagnosis of deep vein thrombosis using the ¹²⁵I-fibrinogen test. Arch. Surg 1972; 104: 152
• 61 Kakkar V. V. Low dose heparin in the prevention of venous thromboembolism. Rationale and results. Thrombos. Diathes. haemorrh 1974; 33: 87-96.
• 62 Kakkar V. V. Low-dose heparin in total hip replacement. Lancet II 1976; 573
• 63 Kakkar V. V. Haemorrhage and low-dose heparin. Lancet II: 1236-1237. 1977;
• 64 Kakkar V. V, Stamatakis J. D, Bentley P. G, Lawrence D, deHaas H. A, Ward V. P. Prophylaxis of postoperative deep vein thrombosis. Synergistic effect of heparin and dihydroergotamine. J. Amer. Med. Ass 1979; 241: 39-42.
• 65 Kakkar V. V. The logistic problems encountered in the multicenter trial of low-dose heparin prophylaxis. Thrombos. Haemostas 1979; 40: 105-113.
• 66 Kiil J, Kiil J, Axelsen F, Andersen D. Prophylaxis against postoperative pulmonary embolism and deep vein thrombosis by low-dose heparin. Lancet l: 1115-1116. 1978;
• 67 Kiil J, Moller J. C. Postoperative deep vein thrombosis of the lower limb and prophylactic value of heparin evaluated by phlebography. Acta Rad. Diag 1979; 20: 507-512.
• 68 Koppenhagen K, Wiechmann A, Frey E, Wenig H. G, Latka H, Zühlke H-V, Tank E, Hardiek J, Ernst H, Häring R. Klinisch experimentelle Ergebnisse mit Heparin-Dihydroergotamin. Dtsch. med. Wschr 1977; 102: 1374-1378.
• 69 Koppenhagen K, Wiechmann A. V, ühlke H, Wenig H. G, Häring R. Leistungsfähigkeit und Risiko der Thromboembolieprophy-laxe in der Chirurgie. Therapiewoche 1979; 29: 5920-5926.
• 70 Koppenhagen K, Häring R. Thromboembo-lieprophylaxe mit vermindertem Blutungsrisiko-Untersuchungen mit Heparin-Dihy-dergot 2500. Med. Welt 1981; b 32: 1020-1021.
• 71 Koppenhagen K, Häring R. Vergleichende Untersuchung zwischen Heparin-Dihydergot 2500 und low-dose Heparin. Klinikarzt 1981; a 10: 782-786.
• 72 Kroese A, Dobloug I. Subcutneous low dose heparin in the prevention of postoperative thromboembolic complications. J. Oslo City Hosp 1976; 26: 45-47.
• 73 Kunz S, Briel R. C, Drähne A. Das Thromboserisiko nach abdominaler und vaginaler Hysterektomie. Geburtsh. u. Frauenheilk 1979; 39: 932-939.
• 74 Kutnowski M, Vadendris M, Steinberger R, Kraytman M. Prevention of postoperative deep vein thrombosis by low dose heparin in urological surgery. Uro. Res 1977; 5: 123-125.
• 75 Lahnborg G, Bergström K, Friman L, Lagergren H. Effect of low-dose heparin on incidence of postoperative pulmonary embolism detected by photoscanning. Lancet l: 329-331. 1974;
• 76 Lahnborg G, Bergström K. Clinical and haemostatic parameters related to thromboembolism and low dose heparin prophylaxis in major surgery. Acta Chir. Scand 1975; 141: 590-595.
• 77 Lawrence J. C, Xabegras A, Gray L, Harn J. M. Seasonal variation in the incidence of deep vein thrombosis. Br. J. Surg 1977; 64: 777-780.
• 78 LeMoine J. R, Moser K. M. Leg scanning with radioisotope-labeled fibrinogen in patients undergoing hip surgery. Comparison with contrast phlebography and lung scans. J. Am. Med. Ass 1980; 243: 2035-2037.
• 79 Lenggenhager K. Genese und Prophylaxe der postoperativen Fernthrombose. Helv. chir. Acta 1957; 24: 316-322.
• 80 Loew D, Brücke P, Simma W, Vinazzer H, Dienstel E, Boehme K. Acetylsalicyclic acidlow dose heparin and a combination of both substances in the prevention of postoperative thromboembolism. A double blind study. Thromb. Res 1977; 11: 81-86.
• 81 MacCarthy T. G, McQueen J, Johnstone F. D, Weston J, Campbell S. A comparison of low-dose subcutaneous heparin and intravenous dextran 70 in the prophylaxis of deep venous thrombosis after gyneocological surgery. J. Obstet. Gynaec. Brit. Cwlth 1974; 57: 486
• 82 Mannucci P. M, Citterio L. E, Panajoto-poulos M. Low-dose heparin and deep-vein thrombosis after total hip replacement. Thrombos. Haemostas 1976; 36: 157-164.
• 83 Marx F. J, Romer R, Sperlich H, Heinze G. H. Thromboseprophylaxe in der Urologie. Verhandlungsbericht Dtsch. Ges. Urologie 1977. Springer: 1978: S370-372.
• 84 Matt E. M, Gruber U. F. Prophylaxe postoperativer thromboembolischer Komplikationen mit subkutan verabreichten kleinen Heparin-Dosen. Fortschr. Med 1977; 95: 669-673.
• 85 Mayo M. E, Halil T, Browse N. L. The incidence of deep-vein thrombosis after prostatectomy. Brit. J. Urol 1971; 43: 738-742.
• 86 Minar E, Ehringer H, Hirschl M, Ingerle H, Konecny U, Marosi L, Endler T, Gabl F, Deutsch E. Transaminasenanstieg: eine weitgehend unbekannte Nebenwirkung der Heparintherapie. Dtsch. med. Wschr 1980; 105: 1713-1717.
• 87 Morris G. K, Henry A. P. J, Preston B. J. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet ll: 797-799. 1974;
• 88 Morris G. K. Prevention of venous thromboembolism. A survey of methods used by orthopaedic and general surgeons. Lancet ll: 572-574. 1980;
• 89 Morris W. T, Hardy A. E. The effect of dihydroergotamine and heparin on the incidence of thromboembolic complications following total hip replacement: a randomized controlled clinical trial. Br. J. Surg 1981; 68: 301-303.
• 90 Moskovitz P. A, Ellenberg S. S, Feffer H. L, Kenmore P. I, Neviaser R. J, Rubin B. E, Varma V. M. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J. Bone Jt. Surg 60A: 1065-1070. 1978;
• 91 Mostbeck A, Partsch H, Köhn H, König B. Lungenembolie bei Bein-Beckenvenenthrombose. Ergebnisse einer prospektivenStudie. Wien. klin. Wschr 1980; 92: 464-471.
• 92 Negus D, Pinto D. J, LeQuesne L. P, Brown N, Chapman M. ¹²⁵I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. Brit. J. Surg 1968; 55: 835-839.
• 93 Negus D, Friedgood A, Cox S. J, Peel A. L. G, Wells B. W. Ultra-low-dose intravenous heparin in the prevention of postoperative deep-vein thrombosis. Lancet l: 891-894. 1980;
• 94 Nicolaides A. N, Field E. S, Kakkar V. V, Yates-Bell A. J, Taylor S, Clarke M. B. Prostatectomy and deep-vein thrombosis. Brit. J. Surg 1972; 59: 487-488.
• 95 Nicolaides A. N, Kakkar V. V, Field E. S, Spindler J. Antibiotics postoperative infection and deep vein thrombosis. Brit. J. Surg 1972; 59: 303
• 96 Nicolaides A. N, Dupont P. A, Desai S, Lewis J. D, Douglas J. N, Dodsworth H, Fourides G, Luck R. J, Jamieson C. W. Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet ll: 890-893. 1972;
• 97 Nicolaides A, Dupont P, Parsons D, Appleberg M, Horan F. T, Esah K. M, Walker C. J. Small dose subcutaneous sodium heparin in preventing deep venous thrombosis after elective hip surgery. Brit. J. Surg 1974; 61: 320
• 98 Nicolaides A. N, Irving D. Clinical factors and the risk of deep venous thrombosis. In Nicolaides A. N. (Ed.) M. T. P. Publishing Co. Ltd; Thromboembolism: S193-204. 1975
• 99 Pachter H. L, Riles T. S. Low dose heparin: Bleeding and wound complications in the surgical patient. A prospective randomized study. Ann. Surg 1977; 186: 669-674.
• 100 Pinto D. J. Controlled trial of an anticoagulant (Warfarin sodium) in the prevention of venous thrombosis following hip surgery. Brit. J. Surg 1970; 57: 349-352.
• 101 Plante J, Boneu B, Vaysse C, Barret A, Gouzi M, Bierme R. Dipyridamol-aspirin versus low doses of heparin in the prophylaxis of deep vein thrombosis in abdominal surgery. Thromb. Res 1979; 14: 399-403.
• 102 Pitt A, Anderson S. T, Haberberger P. G, Rosengarten D. S. Low dose heparin in the prevention of deep vein thromboses in patients with acute myocardial infarction. Amer. Heart J 1980; 99: 574-578.
• 103 Reappraisal of Results of International Multi-center Trial. (Kakkar V. V.). Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet l: 567-569. 1977;
• 104 Rem J, Duckert F, Fridrich R, Gruber U. F. Subkutane kleine Heparindosen zur Thromboseprophylaxe in der allgemeinen Chirurgie und Urologie. Schweiz. med. Wschr 1975; 105: 827-835.
• 105 Roberts V. C, Cotton L. T. Failure of low-dose heparin to improve efficacy of peroperative intermittent calf compression in preventing postoperative deep vein thrombosis. Brit. med. J 458-460. 1975;
• 106 Rosenberg R. D. Actions and interactions of antithrombin and heparin. New Engl. J. Med 1975; 292: 146-151.
• 107 Rosenberg I. L, Evans M, Pollock A. V. Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: A controlled clinical trial. Brit. med. J 1975; 1: 649-651.
• 108 Sagar S, Massey J, Sanderson J. M. Low-dose heparin prophylaxis against fatal pulmonary embolism. Brit. med. J 257-259. 1975;
• 109 Sagar S, Nairn D, Stamatakis J. D, Maffei F. H, Higgisn A. F, Thomas D. P, Kakkar V. V. Efficacy of low-dose heparin in prevention of extensive deep vein thrombosis in patients undergoing total hip replacement. Lancet l: 1151-1154. 1976;
• 110 Schnyder M, Gruber U. F. Prophylaxe postoperativer tiefer Venenthrombosen in der elektiven Hüftchirurgie. Akt. traumatol 1977; 7: 275-280.
• 111 Schöndorf T. H, Hey D. Wirksamkeit von subkutan verabreichtem Heparin zur Thromboseprophylaxe bei großen Hüftgelenkseingriffen. Kontrollierte Studie. Dtsch. med. Wschr 1975; 100: 2014
• 112 Schöndorf T. H, Hey D. Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery. Haemostasis 1976; 5: 250-257.
• 113 Schöndorf T. H, Weber U, Lasch H. G. Niedrig dosiertes Heparin und Acetylsalicylsäure nach elektiven Operationen am Hüftgelenk. Dtsch. med. Wschr 1977; a 102: 1314-1318.
• 114 Schöndorf T. H, Hey D. Modified »low-dose« heparin prophylaxis to reduce thrombosis after hip joint operations. Thrombos. Res 1977; b 12: 153-163.
• 115 Schöndorf T. H. Thromboembolieprophylaxe mit Heparin bei elektiven Hüftgelenksoperationen. Dtsch. med. Wschr 1978; 103: 1877-1881.
• 116 Schöndorf T. H. Thromboembolieprophylaxe mit Heparin und Kombinationspräparaten. Med. Welt 1979; 30: 1157-1161.
• 117 Schöndorf T. H. Prophylaxe von Thromboem-bolien; Wert physikalischer und medikamentöser Maßnahmen. Klinikarzt 1980; 9: 752-763.
• 118 Schöndorf T. H, Lasch H. G. Antithrombin III und factor Xa determination in patients with low-dose heparin and hip surgery. In Lijnen H. R, Collen D, Verstraete M. (Hrsg.) Synthetic Substrates in clinical blood coagulation assays. Devel. Haematol. Vol; The Hague, Boston, London: 1980. 1 51-57.
• 119 Schöndorf T. H, Weber U. Dihydroergotamin oder Dextran zur Verbesserung der Thromboembolieprophylaxe mit Heparin bei Hüftgelenksoperationen. In Deutsch E, Lechner K. (Hrsg.) Fibrinolyse, Thrombose, Hämostase. Schattauer Stuttgart, New York: S313-316. 1980
• 120 Schöndorf T. H, Weber U. Prevention of deep vein thrombosis in orthopaedic surgery with the combination of low dose heparin plus either dihydroergotamine or dextran. Scand. J. Haematol Suppl (Suppl. 36) 1980; 25: 126-134.
• 121 Schöndorf T. H, Weber U, Kessler H. J. Influence of blood volume replacement and anesthetic technique on the incidence of deep vein thrombosis after elective hip surgery. (Abstract). Eur. Surg. Res 1981; 13: 63
• 122 Schwarz N, Feigl W, Neuwirth E, Holzner J. H. Venöse Thrombosen und Lungenembolien im Obduktionsgut. Wien. Klin. Wschr 1976; 88: 423-429.
• 123 Scottish Study Group Maclntyre I. M, Ruckley C. V. Heparin versus dextran in the prevention of deep vein thrombosis. Lancet ll: 118-120. 1974;
• 124 Sebeseri O, Kummer H, Zingg E. Controlled prevention of postoperative thrombosis in urological diseases with depot heparin. Eur. Urol 1975; 1: 229-230.
• 125 Sevitt S, Gallagher N. G. Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet ll: 981-989. 1959;
• 126 Seglias J, Gruber U. F. Dosage in low-dose heparin-prophylaxis. Haemostasis 1979; 8: 361-372.
• 127 Sharnoff J. G. Results in the prophylaxis of postoperative thromboembolism. Surg. Gy-nec. Obst 1966; 123: 303-307.
• 128 Sharnoff J. G. Prevention of sudden cardiopulmonary arrest in the perioperative period with prophylactic heparin. Lancet ll: 292-293. 1969;
• 129 Sharnoff J. G, DeBlasio G. Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet ll: 1006-1007. 1970;
• 130 Stamatakis J. D, Kakkar V. V, Sagar S, Lawrence D, Nairn D, Bentley P. G. Femoral vein thrombosis and total hip replacement. Br. med. J 1977; 2: 223-225.
• 131 Steinmann B, Gertsch R. Über das Vorkommen der Thromboembolien im Alter. Schweiz. med. Wschr 1965; 95: 1039-1045.
• 132 Strand L, Bank-Mikkelsen O. K, Linde-wald H. Small heparin doses as prophylaxis against deep vein thrombosis in major surgery. Acta chir. Scand 1975; 141: 624-627.
• 133 Sturm V, Graber U. F. Wert in der Kumarin-derivate zur Thromboembolieprophylaxe in der Chirurgie. Orthopädie und Gynäkologie. Schweiz. Med. Wschr 1974; 104: 1507-1516.
• 134 Schaub N, Duckert F, Friderich R, Gruber U. F. Häufigkeit postoperativer tiefer Venenthrombosen bei Patienten der allgemeinen Chirurgie und Urologie. Langen-becks Arch. Chir 1975; 340: 23-24.
• 135 Taberner D. A, Poller L, Burslem R. W, Jones J. B. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin prophylaxis of deep vein thrombosis. Brit. med. J 1978; 1: 272-274.
• 136 Towne J. B, Bernhard V. M, Hussey C, Garancis C. J. White clot syndrome. Peripheral vascular complications of heparin therapy. Arch. Surg 1979; 114: 372-377.
• 137 Törngren S. Optimal regimen of low-dose heparin prophylaxis in gastrointestinal surgery. Acta chir. Scand 1979; 145: 87-93.
• 138 Tscherne H, Westermann K, Trentz O, Pretschner P, Mellmann J. Thromboemboli-sche Komplikationen und ihre Prophylaxe beim Hüftgelenksersatz. Unfallheilkunde 1978; 81: 178-187.
• 139 Venous Thrombosis Clinical Study Group Small doses of subcutaneous sodium heparin in the prevention of deep vein thrombosis after elective hip operations. Brit. J. Surg 1975; 62: 348-350.
• 140 Verstraete M. Potential and problems with the clinical use of heparin. Scand. J. Haematol 25 Supp (Suppl. 36) Vol 1-24. 1980;
• 141 Vroonhoven T. J. M. V. van, van Zijl J, Muller H. Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep-venous thrombosis. Lancet 375-377. 1974;
• 142 Warlow C, Terry G, Kenmure A. C. F, Beattie A. G, Ogston D, Douglas A. S. A double blind trial of low doses of subcutaneous heparin in prevention of deep vein thrombosis after myocardial infarction. Lancet ll: 934-936. 1973;
• 143 Wessler S, Yin E. T. Theory and praxis of minidose heparin in surgical patients. A status report. Circulation 1973; 47: 671-676.
• 144 Wessler S. Small doses of heparin and a new concept of hypercoaguability. Thrombos. Diathes. haemorrh 1975; 33: 81-86.
• 145 Wessler S, Gitel S. Low-dose heparin: Is the risk worth the benefit?. Amer Heart J 1979; 98: 94-101.
• 146 White P. W, Richard J. E. Sadd , Nensel E. Thrombotic complications of heparin therapy including six cases of heparin induced skin necrosis. Ann. Surg 1979; 190: 595-608.
• 147 Williams H. T. Prevention of postoperative deep vein thrombosis with peroperative subcutaneous heparin. Lancet l: 950-952. 1971;
• 148 Wyss P. A, Gruber U. F. Was nützt das Einbinden der Beine oder elastische Strümpfe zur Verhinderung postoperativer tiefer Venenthrombosen?. Vasa 1977; 6: 376-380.
• 149 Zekert F, Hofbauer F, Mühlbacher F. Thromboembolieprophylaxe in der Abdominalchirurgie. Vergleich von niedrig dosiertem Heparin, Azetylsalicylsäure und deren Kombination. Münch. med. Wschr 1980; 122: 1495-1498. 49/153